2025年6月20日,欧盟以“不满中国省级招标中‘国产化率’要求”为由,依据《国际采购工具》(IPI)对中国医疗器械企业采取限制措施,禁止中国企业参与欧盟27国价值超过500万欧元(约合人民币 4000 万元)的医疗器械公共采购项目。半月后,我国发布《财政部关于在政府采购活动中对自欧盟进口的医疗器械采取相关措施的通知》(后简称“《通知》”)予以回应,要求采购人采购预算金额4500万元人民币以上的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.